Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-04

FDA Approved: LEVETIRACETAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for levetiracetam submitted by Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)